Barclays Reaffirms Their Hold Rating on Blueprint Medicines (BPMC)

TipRanksJan 9 16:55 · Ratings

Stifel Maintains Blueprint Medicines(BPMC.US) With Buy Rating, Maintains Target Price $155

Futu NewsJan 7 21:31 · Ratings

Stifel Nicolaus Sticks to Its Buy Rating for Blueprint Medicines (BPMC)

TipRanksJan 7 20:45 · Ratings

J.P. Morgan Maintains Blueprint Medicines(BPMC.US) With Buy Rating

Futu NewsJan 6 20:31 · Ratings

Those Who Invested in Blueprint Medicines (NASDAQ:BPMC) Five Years Ago Are up 17%

Simply Wall StJan 6 18:10

Viking Therapeutics Among Potential Buyout Candidates: Oppenheimer

Seeking AlphaJan 4 00:21